glp-1 kidney outcomes news receptor agonists' impact on cardio-renal and mortality in T2D with acute disease GLP-1 Receptor Agonist Outcomes, Safety,

Their findings were striking: AKD patients treated with GLP-1 RAs experienced lower rates of major adverse kidney events (MAKEs), which include complications like the need for dialysis, worsening kidney function, and even death due to kidney failure

What is the difference between LiPo and Li-ion

Liu, Shengnan

While diet and exercise are important for achieving a fit physique, there are times when stubborn fat, especially in the thighs, just wont budge, notes leading cosmetic surgery research

These effects are real but work at a systemic level rather than targeting specific injury sites

ACKNOWLEDGMENTS AND DISCLOSURES Julie Carillon was supported by a CIFRE grant (Convention Industrielle de Formation par la Recherche, n 0417/2010) from the French Association Nationale de la Recherche et de la Technologie and Bionov (Avignon, France), which produces and commercializes an antioxidant product